KGK Science Inc.

KGK

Since 1997, KGK Science has been guiding health product innovators from bright ideas to market-ready success. As a full-service contract research organization (CRO), we specialize in clinical trials, regulatory consulting, and preclinical studies for nutraceuticals, cannabis, hemp, psychedelics, and more. Our strength lies in combining scientific precision with a client-first approach. With 28+ years of experience, 400+ trials, and over 4,000 regulatory projects, we know what it takes to transform promising concepts into trusted, compliant, and market-ready products.

Latest Content

The Next Wave of Probiotics are Not Just for Your Gut

The Next Wave of Probiotics are Not Just for Your Gut

Paid for and content provided by KGK Science

As the field of personalized medicine continues to rise, the gut-brain-microbiota axis will play a crucial role. From your gut to your brain & everything in between learn where the future of probiotics lies.

Related Resources

Hybrid Clinical Trials for Nutraceutical Research

Hybrid Clinical Trials for Nutraceutical Research

Content provided by KGK Science

Product Brochure

Hybrid clinical trials are reshaping the future of nutraceutical and supplement research by combining on-site expertise with virtual convenience.

Regulatory Considerations for Probiotics

Regulatory Considerations for Probiotics

Content provided by KGK Science

White Paper

This latest whitepaper by regulatory experts from KGK Science explores the regulatory pathways that can be taken by manufacturers of products containing new probiotic strains to introduce them to the US and Canadian markets including the major...

Making Health Claims on Infant Nutrition

Making Health Claims on Infant Nutrition

Content provided by KGK Science

White Paper

The market for infant formula has expanded over the past decade and competition is high amongst leading manufacturers to make claims that differentiate their products from others. Ingredients that were previously considered components of specialty...